Business

GLP-1 boom feeds into side effects market

By Sohail Khan 21 August 2026, 12:49 am

Benchmarks
Nifty24,231.85153.55

FEATURED FUNDS★★★★★

Motilal Oswal Midcap Fund Direct-Growth

5Y Return
24.02 %

Invest Now

Enter search text:

Business News›Industry›Cons. Products›Fashion / Cosmetics / Jewellery›GLP-1 drugs create new market for collagen, protein and beauty products in India

Read Today's Paper

GLP-1 drugs create new market for collagen, protein and beauty products in India

Synopsis

The rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developing protein- and fibre-rich foods, nutrition supplements and beauty products aimed at addressing side effects of rapid weight loss.

Govt of India cracks down on GLP-1 drugs: Safety first amid weight-loss hype — Indian companies are launching nutrition and beauty products targeting the side effects of GLP-1 weight-loss drugs as their growing use creates a new consumer demand category.

New Delhi: Companies are rushing to launch products ranging from foods and beverages to face fillers and collagen skincare supplements to capitalise on the side effects of increasingly popular weight-loss drugs such as glucagon-like peptide-1 (GLP-1) medications Ozempic and Mounjaro.

"This is the biggest new demand driver beauty has had in a decade, and it's coming out of a pharmacy, not a trend cycle," said Radhika Ghai, founder of premium cosmetics e-commerce platform Kindlife.

With face fillers, supplements and other products, brands cater to widening demand

"When people lose weight this fast, the medication takes facial volume, skin elasticity and hair along with the fat, so everyone who starts a GLP-1 eventually becomes a customer for a very specific set of products, such as barrier repair, collagen-support skincare and firming body care. What makes this different is that demand grows with the patient base, instead of fading with the season."

Rapid weight loss as a side effect of GLP-1 drugs, a group of prescription medicines used to treat type 2 diabetes and support weight loss, not only depletes body fat but also leads to distinct loss of protein and fibre, a gap companies are competing to be the first ones to fill with nutrition-dense foods and make-up.

Sugar Cosmetics and HUL's Lakme are pushing plumping, non-invasive make-up alternatives such as lip fillers.

The India unit of Nestle said it is working through its joint venture with Dr. Reddy's Laboratories to introduce multiple products for people using GLP-1 drugs by addressing nutrition gaps. "The joint venture between Nestle Health Science and Dr. Reddy's Laboratories has taken a significant step in this space with Celevida GLP+ (a nutrition supplement) for people undergoing GLP-1 therapy," said a spokesperson.

Tata Consumer Products is also readying to enter the segment. Its managing director Sunil D'Souza told ET in July that the company was looking to introduce waters and snacks with protein and fibre to help consumers manage weight-loss side effects by supplementing their food intake. "We are working towards how to play in this space where, because of increasing consumption of GLP-1 products, people consume less protein, fibre, prebiotics and probiotics. We are not looking at reducing portion sizes. Instead, over the next 60 days, we will start entering multiple foods and beverages categories to manage weight loss side effects, where consumers are looking to supplement their food intake," he said.

Add as a Reliable and Trusted News Source
Add Now!

(You can now subscribe to our WhatsApp channel)

(Catch all the Business News, Breaking News and Latest News Updates on The .)

…moreless

(You can now subscribe to our WhatsApp channel)

Read More News on
dr. reddy's laboratoriescollagen supplementsOzempiccollagen skincareweight loss medicationsMounjarobeauty products IndiaNestle Health Science

(Catch all the Business News, Breaking News and Latest News Updates on The .)

…moreless

Enter search text:

Continue reading with one of these options:
Limited Access
Free
Login to get access to some exclusive stories

& personalised newsletters
Login Now

Unlimited Access
Starting @ Rs120/month
Get access to exclusive stories, expert opinions &

in-depth stock reports
Subscribe Now

Unlock Access to All Exclusives with ETPrime FREE TRIAL

15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

Trial offer expiring in00 : 05 : 00

I'd rather pay ₹2599 now

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Prime Account Detected!

It seems like you're already an ETPrime member with

Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

Unlock ETPrime's Exclusive Stories Today!

Subscribe to gain powerful insights on business, stock market and industry trends.

Big Price Drop! Flat 40% Off

Student Only Offer

Already a Member? Sign In now

Already a Member? Sign In now
Already a Member? Sign In now

Offer Exclusively For You

Save up to Rs. 700/-

ON ET PRIME MEMBERSHIP

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get 1 Year Free

With 1 and 2-Year ET prime membership

Avail Offer

Offer Exclusively For You

Get Flat 40% Off

Then ₹ 1749 for 1 year

Avail Offer

Offer Exclusively For You

ET Prime at ₹ 49 for 1 month

Then ₹ 1749 for 1 year

Avail Offer

Special Offer

Get flat 40% off on ETPrime

Avail Offer
Avail Offer

Claim NowAlready a Member? Sign In now

Need Assistance?

Connect with an ETPrime expert for personalized support and guidance

+91 9484700004

' + h3 + '

' + h4 + '

' + listing + '

What’s Included with

ETPrime Membership

1Exclusive Insights That Matter

Uncover the truth with our investigative stories

Make strategic moves using the real-world case studies

Read industry-specific stories to identify emerging trends

Spot opportunities with in-depth insights that matter

Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

What Adani’s US indictment means for India Inc’s overseas fundraising
Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?
Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

The problem with lab grown diamonds
Why a falling rupee is a better option for the economy

A list of top 20 momentum stocks that have delivered massive returns in one year